We are monitoring the impact of COVID-19 on North America Gene Expression Analysis Market Get in touch with us for detailed analysis Know More
Share on

North America Gene Expression Analysis Market Research Report – Segmented By Technology, Consumables, Services , Applications & Country (US, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3391
Pages: 135

North America Gene Expression Analysis Market Size & Growth (2022 to 2027):

As Per the Report, the Size of the North America Gene Expression Analysis Market is valued at USD 1.86 Billion in 2022 and is projected to grow at a CAGR of 8.5%, to reach USD 2.79 Billion by 2027 during the forecast period 2022 to 2027.

The DNA of a cell includes a wealth of information about the cell's characteristics. It is the process by which the information contained in a gene is decoded using various RNAs to produce a functional result such as a protein.

Gene expression analysis allows us to determine the extent to which a gene is expressed and the factors that cause it to be said. Drug development to create pharmaceuticals that can control or boost gene expression when needed can use this research. In addition, some genetic disorders and diseases induced by mutations are treated with gene therapy.

Gene expression has become one of the most critical technologies in various fields, including drug discovery and development, clinical diagnostics, biotechnology, microbiology, and others. In recent years, this approach has become more widely used at various stages of the drug development process.

A growing cancer population is driving the market, increased recognition for gene profiling tests, and increased investments in targeted medication development. The market is also projected to be caused by new technologies that aid in speeding up research.

The market is predicted to grow due to lower gene sequencing prices and various technological advancements such as biochips that aid in better understanding DNA. In addition, the expanding frequency of drug discovery and pharmacogenomics in pharmaceutical businesses and rising healthcare expenditure are accelerating the gene expression analysis market's growth rate.

Government organizations' stringent procedures for approving the latest technology are silently restricting demand for gene expression analysis. Furthermore, this equipment necessitates large sums of money for installation and maintenance in laboratories, which is a significant challenge for market competitors. The market's development rate is being slowed by a scarcity of skilled specialists who can analyze the results. In undeveloped countries, a lack of thorough knowledge of the method is also restricting market demand. Some of the primary issues constraining the gene expression analysis market are a shortage of experienced specialists, a lack of knowledge, and the high cost of the devices utilized for analysis.

This research report on the North America Gene Expression Analysis Market has been segmented and sub-segmented into the following categories

By Technology:

  • DNA Microarray
  • PCR
  • NGS
  • SAGE
  • Northern Blotting

By Consumables:

  • DNA Chips
  • Reagents

By Services:

  • Gene Expression Profiling
  • Bioinformatics

By Application:

  • Research
  • Drug Discovery
  • Diagnostics

By Country:

  • US
  • Canada
  • Rest of North America

Geographically, the North America had the highest revenue share of almost 45 percent.; this is attributed to a large number of important partners. Furthermore, factors such as the development of gene therapy, a focus on gene expression studies, government initiatives, and funding for NGS research are propelling the gene expression analysis market in North America forward. Moreover, Key players are constantly engaged in considerable research and development to produce novel gene expression analysis techniques and methods.

The United States gene expression analysis market dominated the global market, and it is likely to continue its growth during the forecast period. Technological advancement in the healthcare sector, availability of advanced infrastructure, and favorable reimbursement policies fuel market growth. In the United States, the research has the most significant market share owing to the increased emphasis on precision medicine, drug discovery, and diagnostics are rapidly growing segments.

Further, growth can be ascribed to increased funding and R&D activity in gene therapy development. Decibel Therapeutics, Inc., a biotechnology company established in the United States, teamed with Regeneron Pharmaceuticals to develop DB-OTO. DB-OTO is a preclinical stage gene therapy candidate that regulates cochlea hair cells via an exclusive, cell-selective promoter. By 2022, the product is projected to be in clinical trials.

On the other hand, the Canadian gene expression analysis market is anticipated to witness a promising share and contribute to the North American regional market growth. The development of pharmaceutical companies, increasing investment in targeted medicine, and supportive government policies propel market growth.

KEY MARKET PARTICIPANTS

Promising Companies dominating the North America Gene Expression Analysis Market Profiled in the Report are Thermo Fisher Scientific, Inc., Agilent Technologies, Life Technologies, GE Healthcare, Illumina, QIAGEN N.V., Roche, Oxford Gene Technology, PerkinElmer, Affymetrix, Inc., Bio-Rad Laboratories, and Luminex Corporation.                                     

1.Introduction        

                1.1 Market Definition

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases  

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences     

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints

                4.3 Key Challenges     

                4.4 Current Opportunities in the Market    

5. Market Segmentation

                5.1 Consumables   

      5.1.1 Introduction           

      5.1.2 DNA Chips               

      5.1.3 Reagents 

      5.1.4  Y-o-Y Growth Analysis, By Consumables   

      5.1.5  Market Attractiveness Analysis, By Consumables 

      5.1.6  Market Share Analysis, By  Consumables  

                5.2 Technology                 

      5.2.1 Introduction           

      5.2.2 Polymerase Chain Reaction (PCR) 

      5.2.3 DNA Microarray     

      5.2.4 Serial Analysis Of Gene Expression               

      5.2.5 Northern Blotting 

      5.2.6 Next-Generation Sequencing (NGS)           

  5.2.6.1 Cost and Speed Of NGS

  5.2.6.2 Research Laboratories and Academicians Promoting NGS

  5.2.6.3 Substitution Of Microarray Technology By NGS

  5.2.6.4 Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS

  5.2.7 Y-o-Y Growth Analysis, By Technology        

  5.2.8 Market Attractiveness Analysis, By Technology      

  5.2.9 Market Share Analysis, By Technology        

                5.3 Applications     

      5.3.1 Introduction           

      5.3.2 Research  

      5.3.3 Diagnostics              

      5.3.4 Drug Discovery      

      5.3.5 Other Applications               

      5.3.6 Y-o-Y Growth Analysis, By Application         

      5.3.7  Market Attractiveness Analysis, By Application      

      5.3.8  Market Share Analysis, By Application       

                5.4 Services   

      5.4.1 Introduction           

      5.4.2 Gene Expression Profiling Services               

  5.4.2.1 Sequencing Services

  5.4.2.2 Other Services

      5.4.3 Bioinformatics Solutions    

      5.4.4 Y-o-Y Growth Analysis, By Services               

      5.4.5 Market Attractiveness Analysis, By Services             

      5.4.6 Market Share Analysis, By Services              

6. Geographical Analysis

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Consumables

  6.1.3.3 By Technology

  6.1.3.4 By Applications

  6.1.3.5 By Services

      6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Consumables

  6.1.4.3 By Technology

  6.1.4.4 By Applications

  6.1.4.5 By Services

      6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Consumables

  6.1.5.3 By Technology

  6.1.5.4 By Applications

  6.1.5.5 By Services

                6.2 United States  

                6.3 Canada     

7.Strategic Analysis              

                7.1 PESTLE analysis     

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis               

                8.1 Thermo Fisher Scientific Inc.     

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 GE Healthcare 

                8.3 QIAGEN N.V.   

                8.4 Life Technologies 

                8.5 Agilent Technologies    

                8.6 PerkinElmer     

                8.7 Bio-Rad Laboratories    

                8.8 Roche Diagnostics

                8.9 Oxford Gene Technology 

                8.10 Luminex Corporation.

                8.11 Affymetrix                

                8.12 Illumina, Inc.  

9.Competitive Landscape                  

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis   

                9.3 Agreements, Collaborations, and Joint Ventures     

                9.4 New Product Launches     

10.Market Outlook and Investment Opportunities                

Appendix                 

                a) List of Tables                

                b) List of Figures    

  1. North America Gene Expression Analysis Market By Consumables, From 2022 - 2027 ( USD Billion )
  2. North America DNA Chips Market By Region, From 2022 - 2027 ( USD Billion )
  3. North America Reagents Market By Region, From 2022 - 2027 ( USD Billion )
  4. North America Gene Expression Analysis Market By Technology, From 2022 - 2027 ( USD Billion )
  5. North America Polymerase Chain Reaction (PCR) Market By Region, From 2022 - 2027 ( USD Billion )
  6. North America Dna Microarray Market By Region, From 2022 - 2027 ( USD Billion )
  7. North America Serial Analysis Of Gene Expression Market By Region, From 2022 - 2027 ( USD Billion )
  8. North America Next-Generation Sequencing (NGS) Market By Region, From 2022 - 2027 ( USD Billion )
  9. North America Northern Blotting Market By Region, From 2022 - 2027 ( USD Billion )
  10. North America Gene Expression Analysis Market By Application, From 2022 - 2027 ( USD Billion )
  11. North America Research Market By Region, From 2022 - 2027 ( USD Billion )
  12. North America Diagnostics Market By Region, From 2022 - 2027 ( USD Billion )
  13. North America Drug Discovery Market By Region, From 2022 - 2027 ( USD Billion )
  14. North America Other Applications Market By Region, From 2022 - 2027 ( USD Billion )
  15. North America Gene Expression Analysis Market By Service, From 2022 - 2027 ( USD Billion )
  16. North America Gene Expression Profiling Services Market By Region, From 2022 - 2027 ( USD Billion )
  17. North America Bioinformatics Solutions Market By Region, From 2022 - 2027 ( USD Billion )
  18. United States Gene Expression Analysis Market By Consumables, From 2022 - 2027 ( USD Billion )
  19. United States Gene Expression Analysis Market By Technology, From 2022 - 2027 ( USD Billion )
  20. United States Gene Expression Analysis Market By Application, From 2022 - 2027 ( USD Billion )
  21. United States Gene Expression Analysis Market By Service, From 2022 - 2027 ( USD Billion )
  22. Canada Gene Expression Analysis Market By Consumables, From 2022 - 2027 ( USD Billion )
  23. Canada Gene Expression Analysis Market By Technology, From 2022 - 2027 ( USD Billion )
  24. Canada Gene Expression Analysis Market By Application, From 2022 - 2027 ( USD Billion )
  25. Canada Gene Expression Analysis Market By Service, From 2022 - 2027 ( USD Billion )
  26. North America Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )
  27. North America Cost and Speed Of NGS Market By Region, From 2022 - 2027 ( USD Billion )
  28. North America Substitution Of Microarray Technology By NGS Market By Region, From 2022 - 2027 ( USD Billion )
  29. North America Research Laboratories and Academicians Promoting NGS Market By Region, From 2022 - 2027 ( USD Billion )
  30. North America Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS Market By Region, From 2022 - 2027 ( USD Billion )
  31. United States Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )
  32. Canada Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )
  33. North America Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )
  34. North America Cost and Speed Of NGS Market By Region, From 2022 - 2027 ( USD Billion )
  35. North America Substitution Of Microarray Technology By NGS Market By Region, From 2022 - 2027 ( USD Billion )
  36. North America Research Laboratories and Academicians Promoting NGS Market By Region, From 2022 - 2027 ( USD Billion )
  37. North America Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS Market By Region, From 2022 - 2027 ( USD Billion )
  38. United States Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )
  39. Canada Gene Expression Analysis Market By Next-Generation Sequencing (NGS), From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample